Whilst Saxenda is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for obesity treatment, changes in libido are not listed as recognised side effects in the UK Summary of Product Characteristics
Although many studies reveal associations between platelet biomarkers and ASD, there is an important knowledge gap in linking these markers with ASD and explaining the altered platelet phenotypes detected in ASD patients [406]
10.1038/S41598-020-79565-8 65 SoaresP.TroviscoV.RochaA
A., Nicolas, S., & Shivkumar, A
Un efecto adicional importante es la inhibicin de la secrecin de glucagn en niveles de glucosa sobre los normales al ayunar
New research has found that the use of GLP-1 medications, like Ozempic, may also reduce certain violent behaviors